GHRP-2 vs Hexarelin
A neutral, side-by-side comparison of two performance & growth hormone peptides — their mechanisms, dosing ranges, administration routes, side effects, and research evidence. For research and educational purposes only.
GHRP-2
GHRP-2 is a synthetic hexapeptide that acts as a ghrelin mimetic, stimulating the pituitary gland to secrete growth hormone (GH). It is one of the most potent GH secretagogues studied, producing stronger GH pulses than GHRP-6 with comparatively less appetite stimulation.
Full profileHexarelin
Hexarelin is a potent synthetic hexapeptide GHRP (Growth Hormone-Releasing Peptide) that stimulates GH release via the ghrelin receptor. It produces among the highest GH pulses of any GHRP, but also elevates cortisol and prolactin — a trade-off that distinguishes it from more selective options like Ipamorelin.
Full profile| GHRP-2 | Hexarelin | |
|---|---|---|
| Category | Performance & Growth Hormone | Performance & Growth Hormone |
| Also known as | Growth Hormone Releasing Peptide-2, Pralmorelin, KP 102 | Examorelin, EP 23905, MF-6003 |
| Evidence | Preclinical only | Preclinical only |
| Dosing range | 100mcg–300mcg mcg, 1–3 times daily, on an empty stomach | 50mcg–200mcg mcg, 1–3x daily (cycling recommended to prevent desensitization) |
| Administration | Subcutaneous injection, Intramuscular injection | Subcutaneous injection, Intramuscular injection |
| Key side effects | Increased hunger (less than GHRP-6), Elevated cortisol and prolactin at high doses, Water retention, Injection site irritation | Cortisol elevation, Prolactin elevation, Water retention, Increased appetite |
| Cited sources | 3 references | 1 reference |
Key differences
- Frequency: GHRP-2 is typically 1–3 times daily, on an empty stomach; Hexarelin is 1–3x daily (cycling recommended to prevent desensitization).
- Research depth: this profile cites 3 sources for GHRP-2 vs 1 for Hexarelin.
How each works
GHRP-2
GHRP-2 has been extensively studied in both animal and human subjects. Clinical trials have demonstrated significant GH elevation in healthy adults, with a peak GH pulse occurring 15–30 minutes post-injection. Studies show it increases IGF-1 levels with chronic use and may have mild cardioprotective properties. Unlike GHRP-6, it has a lower propensity to stimulate cortisol and prolactin at standard doses.
Hexarelin
Hexarelin produces dose-dependent GH release significantly greater than GHRP-6 or Ipamorelin. It also has direct cardioprotective effects via CD36 receptor binding, independent of GH — making it unique among GHRPs. Studies show protection from ischemic cardiac injury and myocardial fibrosis reduction in animal models. Desensitization occurs with chronic continuous use.
This comparison aggregates public research and structured profile data for informational purposes only. It is not medical advice and does not recommend either compound for human use. Consult a qualified healthcare provider before considering any peptide.